Drug Profile
Research programme: liver X receptor modulators - Phenex Pharmaceuticals
Alternative Names: PX 25593; PX L493; PX L603Latest Information Update: 28 Jul 2022
Price :
$50
*
At a glance
- Originator Phenex Pharmaceuticals
- Class Hepatoprotectants; Small molecules
- Mechanism of Action Liver X receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis
- Discontinued Atherosclerosis; Hypercholesterolaemia
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for preclinical development in Non-alcoholic-steatohepatitis in Germany
- 28 Dec 2020 No recent reports of development identified for preclinical development in Non-alcoholic-fatty-liver-disease in Germany (PO)
- 11 Nov 2016 Preclinical trials in Non-alcoholic fatty liver disease in Germany (PO)